Suppr超能文献

用于预测预后不良的晚期癌症患者生存的姑息性预后指数的评分变化幅度。

Magnitude of score change for the palliative prognostic index for survival prediction in patients with poor prognostic terminal cancer.

作者信息

Hung Chia-Yen, Wang Hung-Ming, Kao Chen-Yi, Lin Yung-Chang, Chen Jen-Shi, Hung Yu-Shin, Chou Wen-Chi

机构信息

Division of Hematology/Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, and School of Medicine, Chang Gung University, No. 5 Fuxing Street, Guishan Township, 333, Taoyuan County, Taiwan.

出版信息

Support Care Cancer. 2014 Oct;22(10):2725-31. doi: 10.1007/s00520-014-2274-4. Epub 2014 May 6.

Abstract

PURPOSE

The use of the palliative prognostic index (PPI) when used only at an initial assessment might be inappropriate as a prognostic tool because it does not reflect the patient's clinical course. The purpose of this study was to assess the utility of PPI score change (∆score) between two assessments as a prognostic tool in terminally ill cancer patients categorized as having a poor prognosis.

METHODS

A total of 1,035 terminally ill cancer patients categorized as having a poor prognosis (initial PPI score >6) under palliative care between January 2006 and December 2011 at a single medical center in Taiwan were selected. Patients were categorized by magnitude of ∆score between the initial PPI and week 1 PPI assessments into five groups (<-20, -20 to 0, 0, 0 to 20, and >20 %) for survival analysis.

RESULTS

The median survival was 22 days (range, 8-180 days) in all patients. Median survival duration was 78, 32, 23, 17, and 14 days, and the death rate at the study end was 78.9, 87.1, 96.2, 100, and 100 % in each group, respectively. The c-statistic value for predicting life expectancy less than 30, 60, and 90 days was significantly higher with magnitude of ∆score than with the initial PPI score (p < 0.05).

CONCLUSIONS

Magnitude of PPI score change within 1-week interval provides a significant difference in survival prediction and is more reliable than initial PPI alone to identify terminally ill cancer patients with better outcome potential in those patients considered to have a poor prognosis.

摘要

目的

仅在初始评估时使用姑息性预后指数(PPI)作为预后工具可能不合适,因为它不能反映患者的临床病程。本研究的目的是评估两次评估之间PPI评分变化(∆评分)作为预后工具在被归类为预后不良的晚期癌症患者中的效用。

方法

选取2006年1月至2011年12月在台湾一家医疗中心接受姑息治疗的1035例被归类为预后不良(初始PPI评分>6)的晚期癌症患者。根据初始PPI与第1周PPI评估之间的∆评分幅度将患者分为五组(<-20、-20至0、0、0至20和>20%)进行生存分析。

结果

所有患者的中位生存期为22天(范围8 - 180天)。每组的中位生存时间分别为78、32、23、17和14天,研究结束时的死亡率分别为78.9%、87.1%、96.2%、100%和100%。预测预期寿命小于30、60和90天的c统计值,∆评分幅度比初始PPI评分显著更高(p < 0.05)。

结论

1周内PPI评分变化幅度在生存预测方面有显著差异,并且在那些被认为预后不良的患者中,比单独使用初始PPI更可靠地识别出具有更好预后潜力的晚期癌症患者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验